Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer.
Saved in:
| Title: | Exploiting dysregulated iron homeostasis to eradicate persistent high-grade serous ovarian cancer. |
|---|---|
| Authors: | Cerra C; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Tancock MRC; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia., Thio N; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Koo A; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Wong A; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., J Cowley K; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Varshney S; Bio21 Mass Spectrometry and Proteomics Facility, The University of Melbourne, Melbourne, VIC, Australia., Willis MO; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Simpson KJ; Victorian Centre for Functional Genomics, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Bio21 Mass Spectrometry and Proteomics Facility, The University of Melbourne, Melbourne, VIC, Australia.; Department of Biochemistry and Pharmacology, The University of Melbourne, Melbourne, VIC, Australia., Bowtell DDL; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Sanij E; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia.; St. Vincent's Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Melbourne, VIC, Australia., Christie EL; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Pearson RB; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Kang J; St. Vincent's Institute of Medical Research, Melbourne, VIC, Australia.; Department of Medicine, St. Vincent's Hospital, The University of Melbourne, Melbourne, VIC, Australia., Chan KT; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia. keefe.chan@petermac.org.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia. keefe.chan@petermac.org. |
| Corporate Authors: | Australian Ovarian Cancer Study Group |
| Source: | Cell death discovery [Cell Death Discov] 2025 Sep 25; Vol. 11 (1), pp. 423. Date of Electronic Publication: 2025 Sep 25. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: United States NLM ID: 101665035 Publication Model: Electronic Cited Medium: Print ISSN: 2058-7716 (Print) Linking ISSN: 20587716 NLM ISO Abbreviation: Cell Death Discov Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2058-7716 |
|---|---|
| DOI: | 10.1038/s41420-025-02716-1 |
